These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 21461749)
1. Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin. Terasmaa A; Soomets U; Oflijan J; Punapart M; Hansen M; Matto V; Ehrlich K; Must A; Kõks S; Vasar E J Physiol Biochem; 2011 Sep; 67(3):381-90. PubMed ID: 21461749 [TBL] [Abstract][Full Text] [Related]
2. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226 [TBL] [Abstract][Full Text] [Related]
3. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Kondo M; Tanabe K; Amo-Shiinoki K; Hatanaka M; Morii T; Takahashi H; Seino S; Yamada Y; Tanizawa Y Diabetologia; 2018 Oct; 61(10):2189-2201. PubMed ID: 30054673 [TBL] [Abstract][Full Text] [Related]
4. Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Akiyama M; Hatanaka M; Ohta Y; Ueda K; Yanai A; Uehara Y; Tanabe K; Tsuru M; Miyazaki M; Saeki S; Saito T; Shinoda K; Oka Y; Tanizawa Y Diabetologia; 2009 Apr; 52(4):653-63. PubMed ID: 19190890 [TBL] [Abstract][Full Text] [Related]
5. Effect of 4-phenylbutyrate and valproate on dominant mutations of WFS1 gene in Wolfram syndrome. Batjargal K; Tajima T; Jimbo EF; Yamagata T J Endocrinol Invest; 2020 Sep; 43(9):1317-1325. PubMed ID: 32219690 [TBL] [Abstract][Full Text] [Related]
6. Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Riggs AC; Bernal-Mizrachi E; Ohsugi M; Wasson J; Fatrai S; Welling C; Murray J; Schmidt RE; Herrera PL; Permutt MA Diabetologia; 2005 Nov; 48(11):2313-21. PubMed ID: 16215705 [TBL] [Abstract][Full Text] [Related]
8. Antidiabetic and antihyperlipidemic activities of Forsythia suspensa (Thunb.) Vahl (fruit) in streptozotocin-induced diabetes mice. Zhang Y; Feng F; Chen T; Li Z; Shen QW J Ethnopharmacol; 2016 Nov; 192():256-263. PubMed ID: 27377336 [TBL] [Abstract][Full Text] [Related]
9. Muscarinic Agonist Ameliorates Insulin Secretion in Wfs1-Deficient Mice. Toots M; Reimets R; Plaas M; Vasar E Can J Diabetes; 2019 Mar; 43(2):115-120. PubMed ID: 30266217 [TBL] [Abstract][Full Text] [Related]
10. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes. Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124 [TBL] [Abstract][Full Text] [Related]
11. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Ishihara H; Takeda S; Tamura A; Takahashi R; Yamaguchi S; Takei D; Yamada T; Inoue H; Soga H; Katagiri H; Tanizawa Y; Oka Y Hum Mol Genet; 2004 Jun; 13(11):1159-70. PubMed ID: 15056606 [TBL] [Abstract][Full Text] [Related]
12. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. Kakiuchi C; Ishigaki S; Oslowski CM; Fonseca SG; Kato T; Urano F PLoS One; 2009; 4(1):e4134. PubMed ID: 19125190 [TBL] [Abstract][Full Text] [Related]
13. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. Liu Z; Li J; Zeng Z; Liu M; Wang M Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884 [TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic effects of aqueous persimmon leaf extract in a murine model of diabetes. Bae UJ; Park SH; Jung SY; Park BH; Chae SW Mol Med Rep; 2015 Aug; 12(2):2547-54. PubMed ID: 25955179 [TBL] [Abstract][Full Text] [Related]
15. Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse. Punapart M; Eltermaa M; Oflijan J; Sütt S; Must A; Kõks S; Schalkwyk LC; Fernandes C; Vasar E; Soomets U; Terasmaa A PPAR Res; 2014; 2014():349525. PubMed ID: 24799886 [TBL] [Abstract][Full Text] [Related]
16. Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice. Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M Horm Metab Res; 2008 Dec; 40(12):880-6. PubMed ID: 18819058 [TBL] [Abstract][Full Text] [Related]
17. Improved glycemic control in mice lacking Sglt1 and Sglt2. Powell DR; DaCosta CM; Gay J; Ding ZM; Smith M; Greer J; Doree D; Jeter-Jones S; Mseeh F; Rodriguez LA; Harris A; Buhring L; Platt KA; Vogel P; Brommage R; Shadoan MK; Sands AT; Zambrowicz B Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E117-30. PubMed ID: 23149623 [TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes. Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120 [TBL] [Abstract][Full Text] [Related]
19. Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism. Mao XQ; Yu F; Wang N; Wu Y; Zou F; Wu K; Liu M; Ouyang JP Phytomedicine; 2009 May; 16(5):416-25. PubMed ID: 19201177 [TBL] [Abstract][Full Text] [Related]